Full Text View
Tabular View
No Study Results Posted
Related Studies
Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
This study has been completed.
Study NCT00008398   Information provided by National Cancer Institute (NCI)
First Received: January 6, 2001   Last Updated: August 19, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Head and Neck Cancer
Oral Complications
Radiation Toxicity
Additional conditions recognized in this trial
Head and Neck Neoplasms
Mucositis
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Mouth Diseases
Neoplasms
Neoplasms by Site
Stomatognathic Diseases
Interventions listed in this trial
sargramostim
quality-of-life assessment
radiation therapy
Sponsors listed in this trial
Radiation Therapy Oncology Group
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services